Market Cap
$124.7B
+2.4% today
Sector & Industry
Healthcare
Biotechnology
SEC Filings
517
Total filings on record
Last Filing
Jan 28, 2026
8-K — Board of Directors Update
Showing 15 filings
| Form Type | Filed Date | Accepted | Description | Accession | Actions |
|---|---|---|---|---|---|
| 10-Q | Jan 28, 2026 | Jan 28, 2026 | Quarterly Report for period ended March 2025 | 0001449933-26-715409 | |
| DEF 14A | Dec 23, 2025 | Dec 23, 2025 | Definitive Proxy Statement for Annual Meeting | 0001449933-26-645396 | |
| S-1 | Nov 27, 2025 | Nov 27, 2025 | Registration Statement | 0001449933-26-299957 | |
| 13F | Nov 3, 2025 | Nov 3, 2025 | Institutional Investment Manager Holdings Report | 0001449933-26-602049 | |
| Form 4 | Oct 10, 2025 | Oct 10, 2025 | Statement of Changes - Sarah Jones | 0001449933-26-270813 | |
| Form 4 | Sep 14, 2025 | Sep 14, 2025 | Statement of Changes - Linda Rodriguez | 0001449933-26-674572 | |
| Form 4 | Aug 16, 2025 | Aug 16, 2025 | Statement of Changes - Linda Rodriguez | 0001449933-26-699548 | |
| S-1 | Jul 20, 2025 | Jul 20, 2025 | Registration Statement | 0001449933-26-125438 | |
| S-1 | Jun 16, 2025 | Jun 16, 2025 | Registration Statement | 0001449933-26-320781 | |
| S-1 | May 22, 2025 | May 22, 2025 | Registration Statement | 0001449933-26-612091 | |
| S-1 | Apr 20, 2025 | Apr 20, 2025 | Registration Statement | 0001449933-25-638902 | |
| S-1 | Mar 22, 2025 | Mar 22, 2025 | Registration Statement | 0001449933-25-374152 | |
| DEF 14A | Feb 20, 2025 | Feb 20, 2025 | Definitive Proxy Statement for Annual Meeting | 0001449933-25-885877 | |
| DEF 14A | Jan 26, 2025 | Jan 26, 2025 | Definitive Proxy Statement for Annual Meeting | 0001449933-25-674342 | |
| 10-K | Dec 29, 2024 | Dec 29, 2024 | Annual Report for fiscal year ended December 2025 | 0001449933-25-773867 |